Through the combination of in vitro and in vivo experiments, along with RNA-seq, proteomics, and targeted metabolomics, we uncovered that MRPL37 may regulate mitochondrial energy metabolism and mitochondrial function, thereby influencing the malignant progression of liver cancer. Here, MRPL37 is linked to liver cancer.